Charles Ryhee
Stock Analyst at TD Cowen
(2.45)
# 2,358
Out of 4,876 analysts
25
Total ratings
52.38%
Success rate
0.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $68.43 | +16.91% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.45 | +22.27% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $728.36 | -10.48% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $143.16 | +18.75% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $10.87 | +442.78% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $167.35 | -56.98% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $0.52 | +154,391.70% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $8.64 | +2,077.19% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $20.40 | +42.16% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $68.43
Upside: +16.91%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.45
Upside: +22.27%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $728.36
Upside: -10.48%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $143.16
Upside: +18.75%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $10.87
Upside: +442.78%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $167.35
Upside: -56.98%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $0.52
Upside: +154,391.70%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $8.64
Upside: +2,077.19%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $20.40
Upside: +42.16%